This includes more than $3 billion in COVID-19 vaccine sales and minimal sales from the RSV vaccine mResvia. This figure was mainly toward the lower end of the company’s previously issued ...

The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

Major stock indexes closed lower on Friday, after the week saw a flurry of events, including DeepSeek scare and earnings ...

The fourth-quarter earnings season for the biotech sector is in full swing this week. A few bigwigs have already reported results. Among these, Bristol Myers reported better-than-expected ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Jan 20 - Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining claims made in a U.S. broadcast that the inoculations have caused a ...

Register and follow to be notified the next time content from Coronavirus Vaccine is published. Link Copied Coronavirus vaccine FAQs including the latest timetable for vaccine rollout and vaccine ...

PARIS - A fringe anti-vaccine movement took advantage of the Covid-19 pandemic to bring conspiracy theories to a much wider audience, propelling dangerous misinformation about life-saving jabs ...

WASHINGTON — Paul Mango, an integral part of the Trump administration’s drive to invent coronavirus vaccines and treatments, has died at 65. Mango joined former President Trump’s Health and ...

SAN FRANCISCO (Reuters) - Biogen expects revenue from new launches to exceed its current sales by 2028 and does not feel the need to chase additional business development deals, the company's CEO ...